Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

50%

2 trials in Phase 3/4

Results Transparency

0 of 1 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 3

1(33.3%)

N/A

1(33.3%)

Phase 4

1(33.3%)

3Total

Phase 3(1)

N/A(1)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials

NCT07178769Not ApplicableRecruiting

Study To Evaluate The Efficacy And Safety Of A Nutritional Supplement Based On Bergamot, Artichoke And Other Ingredients For Reducing Cholesterol Levels In Patients With Hypercholesterolemia (Metachol+)

Role: lead

NCT04981314Phase 4Unknown

Echinacea Drug for Covid-19

Role: collaborator

NCT04210635Completed

Management of Anxiety in Intensive Care Unit Including Olfactotherapy

Role: lead

NCT00235924Phase 3Unknown

Study Assessing the Effects on Endometrium and Breast of Isoflavone in Post Menopausal Women

Role: lead

All 4 trials loaded